Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Desislava Ignatova

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Oncoimmunology|September 22, 2017
PD1-positive tumor-infiltrating lymphocytes are associated with poor clinical outcome after pulmonary metastasectomy for colorectal cancerDagmar Kollmann, Thomas Schweiger, Stefan Schwarz, et al.
Oncology Letters|June 23, 2020
Selective inhibition of HDAC6 sensitizes cutaneous T-cell lymphoma to PI3K inhibitorsMalgorzata Bobrowicz, Aleksander Slusarczyk, Joanna Domagala, et al.
Acta Dermato-Venereologica|April 26, 2018
Aggressive Rare T-cell Lymphomas with Manifestation in the Skin: A Monocentric Cross-sectional Case StudyMarie-Charlotte Brüggen, Katrin Kerl, Eugenia Haralambieva, et al.
Acta Dermato-Venereologica|November 3, 2015
Expression of CD164 on Malignant T cells in Sézary SyndromeEmmanuella Guenova, Desislava Ignatova, Yun-Tsan Chang, et al.
Oncoimmunology|August 8, 2020
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferationIeva Saulite, Desislava Ignatova, Yun-Tsan Chang, et al.
Annals of Surgical Oncology|April 22, 2017
Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal AdenocarcinomaDagmar Kollmann, Desislava Ignatova, Julia Jedamzik, et al.
Nature Communications|January 25, 2024
MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoidesYun-Tsan Chang, Pacôme Prompsy, Susanne Kimeswenger, et al.
Oncoimmunology|June 7, 2018
PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinomaDagmar Kollmann, Desislava Ignatova, Julia Jedamzik, et al.
The British Journal of Dermatology|July 6, 2023
Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in patients with leukaemic cutaneous T-cell lymphomaYi-Chien Tsai, Tanja Schlaepfer, Desislava Ignatova, et al.
Frontiers in Immunology|April 30, 2019
ALCAM Mediates DC Migration Through Afferent Lymphatics and Promotes Allospecific Immune ReactionsAnn-Helen Willrodt, Ann-Charlott Salabarria, Philipp Schineis, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Oncoimmunology|September 22, 2017
PD1-positive tumor-infiltrating lymphocytes are associated with poor clinical outcome after pulmonary metastasectomy for colorectal cancerDagmar Kollmann, Thomas Schweiger, Stefan Schwarz, et al.
Oncology Letters|June 23, 2020
Selective inhibition of HDAC6 sensitizes cutaneous T-cell lymphoma to PI3K inhibitorsMalgorzata Bobrowicz, Aleksander Slusarczyk, Joanna Domagala, et al.
Acta Dermato-Venereologica|April 26, 2018
Aggressive Rare T-cell Lymphomas with Manifestation in the Skin: A Monocentric Cross-sectional Case StudyMarie-Charlotte Brüggen, Katrin Kerl, Eugenia Haralambieva, et al.
Acta Dermato-Venereologica|November 3, 2015
Expression of CD164 on Malignant T cells in Sézary SyndromeEmmanuella Guenova, Desislava Ignatova, Yun-Tsan Chang, et al.
Oncoimmunology|August 8, 2020
Blockade of programmed cell death protein 1 (PD-1) in Sézary syndrome reduces Th2 phenotype of non-tumoral T lymphocytes but may enhance tumor proliferationIeva Saulite, Desislava Ignatova, Yun-Tsan Chang, et al.
Annals of Surgical Oncology|April 22, 2017
Expression of Programmed Cell Death Protein 1 by Tumor-Infiltrating Lymphocytes and Tumor Cells is Associated with Advanced Tumor Stage in Patients with Esophageal AdenocarcinomaDagmar Kollmann, Desislava Ignatova, Julia Jedamzik, et al.
Nature Communications|January 25, 2024
MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoidesYun-Tsan Chang, Pacôme Prompsy, Susanne Kimeswenger, et al.
Oncoimmunology|June 7, 2018
PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinomaDagmar Kollmann, Desislava Ignatova, Julia Jedamzik, et al.
The British Journal of Dermatology|July 6, 2023
Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in patients with leukaemic cutaneous T-cell lymphomaYi-Chien Tsai, Tanja Schlaepfer, Desislava Ignatova, et al.
Frontiers in Immunology|April 30, 2019
ALCAM Mediates DC Migration Through Afferent Lymphatics and Promotes Allospecific Immune ReactionsAnn-Helen Willrodt, Ann-Charlott Salabarria, Philipp Schineis, et al.
Pageof 3